Good morning! Another interesting morning too, with lots going on. I'm increasingly looking for opportunities in the oil sector, and over the weekend I did an oil sector special audiocast, with an expert in the field, Paul Curtis. Click here to listen to me interviewing him yesterday. There's no angle on these audiocasts, they're free, with no advertising. I just enjoy doing them, and think they are interesting, and other people seem to like them.

Stop Press: Mello Beckenham, at Sea Salt restaurant, is next Monday, 19 Jan, and the company presenting is a micro cap HML Holdings (LON:HMLH) which is a property management company. Please see the usual webpage here for details on how to reserve a place.


SkyePharma (LON:SKP)

Share price: 284p (down 17% today)
No. shares: 104.8m
Market Cap: £297.6m

For more information, there is a link embedded in the picture of their website above. Just click on the nice lady looking wistful as she is about to take a pill.

Trading update - this sounded fine to me when I first read it, but the market seems to disagree, with the shares currently down 17% to 284p, so I've clearly missed something that the market doesn't like. It's encouraging to see that they are trading in line with expectations, and that the net cash position looks fine;


54b39fe4470d5SKP_TU.JPG

This bit sounds mildly negative;

54b3a1c756614SKP_negative.JPG

R&D spending is set to rise, from around £4.5m in 2014 to around £10m in 2015. Is that negative? I wouldn't say so - a drug development company should be spending money on R&D, so it seems odd if this point has triggered the sell-off today.

The Directorspeak at the end sounds positive, so all in all, I'm not terribly sure why the market has marked down these shares so heavily today. I'm wondering if this might be a good opportunity to top up? Think I'll wait until I've seen some updated broker notes, as it's important to know you own limitations - pharmas are not an area that I know well enough to get heavily involved in. Although the figures do seem to show SKP as being a potential…

Unlock the rest of this article with a 14 day trial

Already have an account?
Login here